Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Oxford Biomedica Share News (OXB)
OXB Share
Price
OXB Share
News
OXB Share
Chat
OXB Share
Trades528
OXB
Live RNS
OXB Share
Charts
OXB Level 2
Console
OXB Live
Share Price
OXB Broker
Ratings
OXB Directors
Deals
OXB Financial
Diary
OXB
Fundamentals
OXB Short
Positions1
OXB
Media
OXB Company
Research
OXB Company
Timeline1
Share Price Information for Oxford Biomedica (OXB)
Last checked at -
Last checked at 
Intraday Oxford Biomedica Share Chart
Oxford Biomedica News
LONDON BROKER RATINGS: Goldman raises Croda; Jefferies likes Diploma
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:
LONDON BRIEFING: GSK gains Japan nod; Anglo to delist shares in Zurich
(Alliance News) - GSK makes regulatory progress in Japan for a cancer therapy, Anglo American moves to delist from the Swiss exchange as part of its r...
IN BRIEF: Oxford Biomedica inks new licensing and option deal
Oxford BioMedica PLC - Oxford, England-based gene and cell therapy developer - Enters a five-year licensing and option agreement with Viral Vector Man...
EQT abandons Oxford BioMedica takeover bid after proposals rejected
(Alliance News) - EQT Fund Management SARL confirmed on Wednesday it has no intention of making an offer for Oxford BioMedica PLC.
EQT not planning to bid for Oxford Biomedica
(Sharecast News) - Oxford Biomedica shares slumped on Wednesday after Swedish private equity firm EQT said it was not planning to make an offer for th...
Oxford BioMedica revenue climbs 30% in 2025 as backlog grows
(Alliance News) - Oxford BioMedica PLC on Tuesday said it expects to report revenue at the upper end of guidance as contracted orders increased.
Oxford Biomedica FY revenues grow, one‑off gain props up earnings
(Sharecast News) - Contract development and manufacturing firm Oxford Biomedica said on Tuesday that it expects to report a strong rise in full year r...
Follow the stocks
